Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The expression of HMGA genes is regulated by their 3′UTR

Oncogene volume 20, pages 4537–4541 (2001)Cite this article

Abstract

Many benign mesenchymal tumors are characterized by chromosomal abnormalities of the regions 12q15 or 6p21.3 leading to aberrant expression of either HMGA2 (formerly HMGIC) or HMGA1 (formerly HMGIY). The proteins of both genes belong to the HMGA (formerly HMGI(Y)) family of architectural transcription factors. As a rule, aberrant HMGA transcripts found in a variety of benign tumors have intact coding regions at least for the DNA binding domains with a truncation of their 3′ untranslated regions. Adding this to the finding that an altered HMGA protein level is not always correlated with an increased amount of corresponding mRNA indicates a posttranscriptional expression control mediated by regulatory elements within the 3′UTR. To check if HMGA expression is under control of such elements we performed luciferase assays with several HMGA2 and HMGA1 3′UTRs of different length. Experiments showed that an up to 12-fold increase in luciferase activity is obtained by the truncation of the 3′UTRs suggesting that the expression of HMGA2 and HMGA1 is controlled by negatively acting regulatory elements within their 3′UTR. Chromosomal aberrations affecting the HMGA genes may therefore influence their expression by an altered stability of the truncated transcripts as a result of the cytogenetic aberrations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abe N, Watanabe T, Masaki T, Mori T, Sugiyama M, Uchimura H, Fujioka Y, Chiappetta G, Fusco A, Atomi Y . 2000 Cancer Res. 60: 3117–3122

  • Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K . 1995 Cell 82: 57–65

  • Ayoubi TA, Jansen E, Meulemans SM, Van de Ven WJ . 1999 Oncogene 18: 5076–5087

  • Battista S, Fidanza V, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H, Santoro M, Croce CM, Fusco A . 1999 Cancer Res. 59: 4793–4797

  • Beaujean N, Bouniol-Baly C, Monod C, Kissa K, Jullien D, Aulner N, Amirand C, Debey P, Kas E . 2000 Dev. Biol. 221: 337–354

  • Bussemakers MJ, van de Ven WJ, Debruyne FM, Schalken JA . 1991 Cancer Res. 51: 606–611

  • Bustin M, Reeves R . 1996 Prog. Nucleic Acid Res. Mol. Biol. 54: 35–100

  • Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A . 1986 Proc. Natl. Acad. Sci. USA 83: 1670–1674

  • Chen CY, Shyu AB . 1994 Mol. Cell. Biol. 14: 8471–8482

  • Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A . 1995 Oncogene 10: 1307–1314

  • Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A, Fusco A . 1996 Oncogene 13: 2439–2446

  • Decker CJ, Parker R . 1995 Curr. Opin. Cell. Biol. 7: 386–392

  • Eckner R, Birnstiel ML . 1989 Nucleic Acids Res. 17: 5947–5959

  • Fajardo MA, Haugen HS, Clegg CH, Braun RE . 1997 Dev. Biol. 191: 42–52

  • Friedmann M, Holth LT, Zoghbi HY, Reeves R . 1993 Nucleic Acids Res. 21: 4259–4267

  • Geurts JM, Schoenmakers EF, Van de Ven WJ . 1997 Cancer Genet. Cytogenet. 95: 198–205

  • Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Philp R, Crane-Robinson C, Nicolas RH . 1987 EMBO J. 6: 1981–1987

  • Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH . 1989 Exp. Cell Res. 184: 538–545

  • Goodwin GH, Cockerill PN, Kellam S, Wright CA . 1985 Eur. J. Biochem. 149: 47–51

  • Izquierdo JM, Cuezva JM . 1997 Mol. Cell Biol. 17: 5255–5268

  • Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJ, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J . 1996a Oncogene 12: 515–521

  • Kazmierczak B, Pohnke Y, Bullerdiek J . 1996b Genomics 38: 223–226

  • Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, Bullerdiek J . 1998 Genes Chromosomes Cancer 23: 279–285

  • Klotzbücher M, Wasserfall A, Fuhrmann U . 1999 Am. J. Pathol. 155: 1535–1542

  • Lanahan A, Williams JB, Sanders LK, Nathans D . 1992 Mol. Cell Biol. 12: 3919–3929

  • Malter JS . 1989 Science 246: 664–666

  • Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, Goodwin GH . 1991 Nucleic Acids Res. 19: 6793–6797

  • Russell JE, Morales J, Liebhaber SA . 1997 Prog. Nucleic Acid. Res. Mol. Biol. 57: 249–287

  • Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ . 1995 Nat. Genet. 10: 436–444

  • Tamimi Y, van der Poel HG, Denyn MM, Umbas R, Karthaus HF, Debruyne FM, Schalken JA . 1993 Cancer Res. 53: 5512–5516

  • Tkachenko A, Ashar HR, Meloni AM, Sandberg AA, Chada KK . 1997 Cancer Res. 57: 2276–2280

  • Xiao S, Lux ML, Reeves R, Hudson TJ, Fletcher JA . 1997 Am. J. Pathol. 150: 901–910

  • Xu N, Chen CY, Shyu AB . 1997 Mol. Cell Biol. 17: 4611–4621

  • Zhou X, Benson KF, Ashar HR, Chada K . 1995 Nature 376: 771–774

Download references

Author information

Authors and Affiliations

  1. Center for Human Genetics, University of Bremen, Leobenerstr, Bremen, ZHG, 28359, Germany

    Lars Borrmann, S Wilkening & J Bullerdiek

Authors
  1. Lars Borrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Wilkening
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Bullerdiek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Bullerdiek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borrmann, L., Wilkening, S. & Bullerdiek, J. The expression of HMGA genes is regulated by their 3′UTR. Oncogene 20, 4537–4541 (2001). https://doi.org/10.1038/sj.onc.1204577

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204577

Keywords

This article is cited by

Search

Advanced search

Quick links